HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
Search for topics & keywords
Search
TRANSCENTA-B (06628) repurchased 10,000 shares on January 10th.
10/01/2025
GMT Eight
TRANSCENTA-B (06628) announced on January 10, 2025 that it will spend 6100 Hong Kong dollars to repurchase 10,000 shares.
Weichai Power (02338) intends to further repurchase and cancel 300,000 restricted shares.
Hubei Biocause Pharmaceutical (000627.SZ): CHINA BEST Life Insurance's cumulative original insurance premium income in 2024 is about 34.639 billion yuan.
RECOMMEND
US Stock Market Move | The United States plans to tighten regulations on the export of AI chips, causing AMD Semiconductor (AMD.US) to fall nearly 5%.
10/01/2025
US Stock Market Move | Lowering the 2025 fiscal year performance guidance, the constellation brand (STZ.US) plummeted more than 10%.
10/01/2025
US Stock Market Move | Los Angeles fire causes widespread damage, insurance sector plunges.
10/01/2025
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.
Contact: contact@gmteight.com